NCT04580446View on ClinicalTrials.gov

HYHOPE: De-intensified Hypofractionated Radiation Therapy for HPV-associated Oropharynx Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

December 3, 2020

Primary Completion Date

December 20, 2024

Study Completion Date

December 20, 2024

Conditions
Human Papillomavirus-Related CarcinomaOropharyngeal Cancer
Interventions
RADIATION

Hypofractionated intensity modulated radiotherapy

Hypofractionated intensity modulated radiotherapy with concurrent chemotherapy (weekly cisplatin)

Trial Locations (1)

75390

University of Texas Southwestern Medical Center, Dallas

All Listed Sponsors
collaborator

Gateway for Cancer Research

OTHER

lead

University of Texas Southwestern Medical Center

OTHER

NCT04580446 - HYHOPE: De-intensified Hypofractionated Radiation Therapy for HPV-associated Oropharynx Cancer | Biotech Hunter | Biotech Hunter